CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. 期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 卷号: 36, 期号: 30, 页码: JCO2018783183
作者:  Qin, Shukui;  Li, Jin*;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/03
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial. 期刊论文
JAMA, 2018, 卷号: 319, 期号: 24, 页码: 2486-2496
作者:  Li, Jin;  Qin, Shukui*;  Xu, Rui-Hua;  Shen, Lin;  Xu, Jianming
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/03
The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/beta-catenin signaling and is frequently silenced in multiple tumors. 期刊论文
PLOS ONE, 2011, 卷号: 6, 期号: 11, 页码: e27346
作者:  Shu, Xing-sheng*;  Geng, Hua;  Li, Lili;  Ying, Jianming;  Ma, Chunhong
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/03


©版权所有 ©2017 CSpace - Powered by CSpace